In a two-center longitudinal study, the authors present evidence in support of cholinergic system subgroups in Parkinson’s disease (PD), which exhibit both downregulation and upregulation of signaling. Subgroup-specific cholinergic changes associated with clinical PD features.
- Nicolaas I. Bohnen
- Stiven Roytman
- Prabesh Kanel
